Capital Fund Management S.A. Reata Pharmaceuticals Inc Transaction History

Capital Fund Management S.A.

  • $36 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$24.12 - $39.6 $348,606 - $572,338
-14,453 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$25.61 - $110.96 $370,141 - $1.6 Million
14,453 New
14,453 $381,000
Q2 2020

Aug 13, 2020
SELL
$126.3 - $176.56 $1.13 Million - $1.58 Million
-8,966 Closed
0 $0
Q1 2020

May 13, 2020
BUY
$124.16 - $247.74 $1.11 Million - $2.22 Million
8,966 New
8,966 $1.29 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email